Objective:
To provide insights into the Stellest spectacle lenses for myopia management and compare them with existing options.
Key Findings:
- 0
Interpretation:
Stellest lenses represent a promising new option for myopia management, leveraging advanced technology to effectively reduce progression.
Limitations:
- Long-term efficacy and safety data beyond 2 years are not yet available.
- The study results are based on Essilor's own clinical data.
Conclusion:
Stellest lenses offer a new avenue for myopia management, enhancing the options available to practitioners and potentially improving patient outcomes.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.